Manuel Pombo-Suarez

6PUBLICATIONS
49CO-AUTHORS
Rheumatology and arthritisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 15, 2024
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.

Lykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis

|Dec 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).

Romain Aymon, Denis Mongin, Sytske Anne Bergstra

|Dec 01, 2022
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.

Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis

|Sep 13, 2022
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.

Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino

|Jun 15, 2022
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.

Kim Lauper, Michele Iudici, Denis Mongin

|Feb 03, 2021
Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain.

Manuel Pombo-Suarez, Jose Ramon Maneiro Fernandez, Juan Jesus Gomez-Reino

Pageof 1

Frequent Collaborators

5 joint publications

Florenzo Iannone

3 joint publications

Kim Lauper

3 joint publications

Sytske Anne Bergstra

3 joint publications

Axel Finckh